TELETRADER News
8/17/2021, 4:47 PM
(Source: TeleTrader)
Moderna jumps 6% on wider UK jab approval
Shares of Moderna surged over 6% on Tuesday after the United Kingdom approved the company's COVID-19 vaccine for use in adolescents.
Earlier in the day, the UK Medicines and Healthcare products Regulatory Agency (MHRA) said the jab "is safe and effective" for those aged between 12 and 17.
Moderna's stock rallied 6.10% to $396.34 at 10:45 am ET.